Related Experiment Video
Updated: Jul 14, 2026
09:34
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Prevention and control of tuberculosis.
1Department of Medicine, University of Nairobi, P. O. Box 19676, Nairobi, Kenya.
African Journal of Health Sciences
|January 1, 1997
Summary
Tuberculosis control relies on case-management, chemoprophylaxis, and vaccination. Strategies like multidrug chemotherapy and isoniazid preventive therapy show promise, but adherence and cost remain challenges for public health.
Area of Science:
- Public Health
- Infectious Diseases
- Epidemiology
Background:
- Tuberculosis (TB) is a resurging global public health concern.
- Effective TB control requires multifaceted strategies including case-management, chemoprophylaxis, and vaccination.
- Current control methods face challenges such as drug compliance, high costs, and variable vaccine efficacy.
Purpose of the Study:
- To review current strategies for tuberculosis control.
- To evaluate the effectiveness and challenges of different TB control interventions.
- To highlight the importance of adherence and cost-effectiveness in TB management.
Main Methods:
- Review of existing literature on tuberculosis control measures.
- Analysis of case-management, chemoprophylaxis (isoniazid preventive therapy), and vaccination (BCG).
- Examination of control measures for healthcare workers, including engineering, administrative, and personal respiratory strategies.
Main Results:
- Multidrug chemotherapy aims to halt TB transmission but is limited by poor patient adherence and high drug costs.
- Bacilli Calmette Guerin (BCG) vaccination shows variable efficacy (around 50%), with cost-effectiveness yet to be fully established.
- Isoniazid preventive therapy (IPT) demonstrates high efficacy with good medication adherence (≥80%).
- Implementation of engineering, administrative, and respiratory measures in the USA led to a significant reduction in TB risk among healthcare workers.
Conclusions:
- Tuberculosis control necessitates a combination of effective chemotherapy, preventive therapies, and vaccination.
- Improving drug compliance and addressing the cost of treatments are critical for successful case-management.
- Targeted interventions for healthcare workers have proven effective in reducing occupational TB transmission.
Related Concept Videos
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:25Transmission-based Precautions II: Airborne and Protective Environment
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:23Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
01:24Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.